SLATE KEY CITY — Utah is witnessing more cases of monkeypox, which is currently a nationwide public health emergency. However, epidemiologists emphasis that a certain population is where this virus is most prevalent. Local health agencies and the Utah Department of Health and Human Services are striving to inform and safeguard that people.
In Utah, there have been 43 confirmed and probable cases of monkeypox recorded since May, with Salt Lake County accounting for the majority of those cases. In Salt Lake County, there are 34 cases as of August 3; in Davis County, there are 2, in Utah County, there are 4, and in the Weber/Morgan region, there are 3.
According to state epidemiologist Dr. Leisha Nolen, “We are witnessing a number of monkeypox cases, and they are increasing in the most recent week.” “We’re seeing more cases and transmission.” Despite the fact that monkeypox mainly affects guys who have sex with other men, it can infect anyone through close skin-to-skin contact. In Utah, she explained, “our cases involve intimate interaction.”
- How Much Cooler Will It Be This Weekend In Salt Lake City?
- 5800 New Covid-19 Cases, 16 Deaths In Utah, Including A Salt Lake County Youngster!
“Consider a private exchange. Consider prolonged, intimate contact with a person who is actively infected with monkeypox “Dr. Brandon Webb, a specialist in infectious diseases with Intermountain Healthcare, warned. According to Nolen, local health departments are striving to stop the spread of diseases in high-risk areas by spotting infections early, controlling exposures, and immunizing those who are most vulnerable.
All of us are hoping we can stop this before it spreads further and prevent it from becoming a chronic illness, she said. “For the majority of members of the community, the risk of monkeypox is currently low to zero. It is intensely focused on a very narrow segment of our community, specifically males who have sex with men, “added Webb.
There is a shortage of vaccines. Utah will only receive 6,300 doses from the US Centers for Disease Control and Prevention for the next two months, with no additional doses being distributed until October. According to Webb, the antiviral medication Tecovirimat, or TPOXX, is helping. In Utah, “we’ve already started employing it,” he declared. “This particular antiviral has been used to treat a number of patients with some degree of success.”
He is hopeful that it would hasten rehabilitation, aid with pain management, and get rid of the rash. Nolen asserted, “I think we’ve really been on top of it.” We’ve discovered cases pretty early in the epidemic, which, in my opinion, demonstrates how carefully our doctors are keeping an eye on things and how well our public health departments collaborate with those doctors. Monkeypox symptoms should be investigated, evaluated by a physician, and isolated.